<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00847743</url>
  </required_header>
  <id_info>
    <org_study_id>KLRI-2007-03</org_study_id>
    <nct_id>NCT00847743</nct_id>
  </id_info>
  <brief_title>Study on Whether Tart Cherry Juice Can Reduce Oxidative Stress and Inflammation</brief_title>
  <official_title>Effects of Tart Cherry Juice on Oxidative Stress and Inflammation in Older Men and Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kronos Longevity Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kronos Longevity Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oxidative stress has been linked to many diseases associated with aging, including coronary&#xD;
      heart disease and Alzheimer's disease. Antioxidants and special proteins in the body work&#xD;
      together to help prevent damage by free radicals. Some studies have indicated that as people&#xD;
      age, they are less able to fight off oxidative stress and have increased levels of&#xD;
      inflammation.&#xD;
&#xD;
      Tart cherries are known to be rich in antioxidants and plant-nutrients. The product we are&#xD;
      using in this study is an all-natural tart cherry juice, mixed with apple juice concentrate&#xD;
      and containing no additives and no preservatives.&#xD;
&#xD;
      We hope to learn whether antioxidant supplementation, such as tart cherry juice, can&#xD;
      measurably decrease oxidative damage and inflammation associated with aging.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives&#xD;
&#xD;
      The primary objective of this pilot study is to investigate whether tart cherry juice&#xD;
      consumption can reduce oxidative stress in older adults as measured by attenuation of&#xD;
      F2-isoprostane responses to a forearm ischemia-reperfusion, and a decrease in urinary&#xD;
      excretion products of oxidative damage. The secondary objective is to examine whether&#xD;
      age-sensitive markers of inflammation are reduced in response to the cherry juice&#xD;
      consumption.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasma F2-isoprostane response to a forearm ischemia-reperfusion challenge.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary markers of oxidative damage.</measure>
  </secondary_outcome>
  <enrollment type="Actual">12</enrollment>
  <condition>Oxidative Stress</condition>
  <condition>Antioxidant Capacity</condition>
  <condition>Inflammation</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Tart Cherry Juice</intervention_name>
    <description>8 fl.oz. twice per day</description>
    <other_name>CherryPharm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  men and women, ages 55-80y, in good health, with &gt;8 years of education&#xD;
&#xD;
          -  non-smoker&#xD;
&#xD;
          -  able to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  use of anti-oxidant supplements, in excess of a standard multi-vitamins&#xD;
&#xD;
          -  current hormone replacement therapy&#xD;
&#xD;
          -  any history of significant chronic disease&#xD;
&#xD;
          -  uncontrolled hypertension&#xD;
&#xD;
          -  body mass index (BMI) &gt; 30 kg/m2&#xD;
&#xD;
          -  high physical activity level, as determined by questions on the screening&#xD;
             questionnaire&#xD;
&#xD;
          -  use of anti-inflammatory medication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tinna Traustadottir, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kronos Longevity Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kronos Longevity Research Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <study_first_submitted>February 17, 2009</study_first_submitted>
  <study_first_submitted_qc>February 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2009</study_first_posted>
  <last_update_submitted>February 18, 2009</last_update_submitted>
  <last_update_submitted_qc>February 18, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2009</last_update_posted>
  <responsible_party>
    <name_title>Tinna Traustad√≥ttir, Ph.D.</name_title>
    <organization>Kronos Longevity Research Institute</organization>
  </responsible_party>
  <keyword>oxidative stress</keyword>
  <keyword>aging</keyword>
  <keyword>ischemia-reperfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

